Japan Tobacco, Inc.

Japan Tobacco, Inc.

Japan Tobacco, Inc.

Overview
Date Founded

1985

Headquarters

2-2-1 Toranomon,Minato-Ku,Tokyo 105-8422

Type of Company

Public

Employees (Worldwide)

44.7K

Industries

Tobacco
Wholesale: Consumer Non-Durables/Sundries
Restaurants
Food
Beverages
Livestock & Animals

Company Description

Japan Tobacco, Inc. engages in the manufacture and sale of tobacco, pharmaceutical and processed food products. It operates through the following business divisions: Domestic Tobacco, Overseas Tobacco, Pharmaceutical, and Processed Food. The Domestic Tobacco division deals with the production and sale of tobacco products in domestic areas. The Overseas Tobacco division manufactures and markets tobacco products worldwide. The Pharmaceutical division develops, manufactures, and sells prescription drugs. The Beverage division manufactures and sells coffee and flavored water drinks. The Processed Food division offers processed food products that include frozen noodles, frozen and packed cooked rice and frozen baked bread, and seasonings. The company was founded on April 1, 1985 and is headquartered in Tokyo, Japan.

Website
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer

Executive Deputy President

Executive Deputy President

Executive Deputy President & Representative Director

Managing Executive Officer & Head-China Division

Chief Strategy Officer

Chief Human Resources Officer

Executive Officer & Head-Human Resources

Head of Beverage Business

Subscribe now to see full list of current and former executives
Board of Directors

Independent Outside Director at The Ogaki Kyoritsu Bank Ltd.

Outside Director at LIXIL Group Corp.

Chairman at Sumitomo Corp. of Americas

Executive Deputy President & Representative Director at Japan Tobacco, Inc.

President & Chief Executive Officer at Japan Tobacco, Inc.

Executive Deputy President at Japan Tobacco, Inc.

Former Chief Executive Officer at Japan Tobacco, Inc.

Chief Strategy Officer at Japan Tobacco, Inc.

Subscribe now to see full list of current and former board members
Paths to Japan Tobacco, Inc.
Potential Connections via
Relationship Science
You
Japan Tobacco, Inc.
Owners & Shareholders
Details Hidden

GIC-IM is an active, prudent manager which aims to enhance the worldwide purchasing power of Singapore's reserves through their 'integrated diversity' investment strategy where GIC operates as a single integrated organization while fully exploiting their in-house asset class expertise and experience. They invest globally in a range of asset classes including equities, fixed-Income, real estate, private equity, infrastructure, marketable alternatives and natural resources.The firm's Board of Directors sets the policy asset mix and decides on a policy portfolio which specifies the allocation of funds to eligible asset classes. Investment decisions are based on analysis of fundamentals in line with long-term sustainable performance.The GIC-IM management team decides how to implement the asset policy mix in terms of the various investment strategies, proportion of funds to be actively/passively managed, allocation of risk capital and the selection of managers. The firm's portfolio managers then construct portfolios based on considerations of currency management, country selection, industry/sector allocation, yield curve management and security selection.

Details Hidden

NAM-J is an active, value-oriented manager with a global perspective and a medium- to long-term outlook. Their investment philosophy emphasizes multi-faceted research shared internationally throughout the group, and local expertise contributed by their overseas offices. Their strong research capabilities, supported and integrated globally by proprietary systems, include fundamental analysis, company visits, market research, credit analysis, macroeconomic projections and quantitative analysis. Their global asset allocation strategy is determined by an investment committee at the group level.The firm uses a variety of strategies including active, passive and active quantitative. Their funds are invested in domestic and global equity and fixed-income, as well as in Japanese money market instruments. The majority of their investments are in equity, complemented by a substantial minority of bonds and investments in private placement funds. The firm manages a range of Japanese ETFs including sector funds.NAM-J's investment process is team-based and combines bottom-up and top-down strategies, with a bias towards stockpicking.

Details Hidden

NIM is a thematic, team-oriented manager which conducts in-house research to identify themes and trends that influence, or are likely to influence, economies or stock markets globally. They believe that 'change leads to opportunity' and encourage individual thinking which is crucial to identify the companies that offer the best growth prospects.The firm is a holistic investor which follows global trends and economic developments as they interpret them. Their economists, analysts, portfolio managers and strategists develop and apply themes which are their interpretation of the forces of global change affecting companies. They focus their research on the areas that they believe are most likely to yield the best performing securities.NIM's analysts seek out companies with attractive value and strong fundamentals which may benefit from one or more themes. Constant communication and research prioritization meetings between analysts and other investment professionals underpins the firm's research process, and results in development of their recommended list.Portfolio managers construct equity and fixed-income model portfolios in teams. The interaction between team members ensures a cohesive, consistent approach to stock selection and implementation. Risk is assessed throughout the investment process and a specialist team formally monitors portfolio risk using risk models and other controls.

Subscribe now to see full details
Recent Transactions
Details Hidden

Japan Tobacco, Inc. purchases National Tobacco Enterprise (Ethiopia) Share Co.

Details Hidden

Japan Tobacco, Inc., JT International (Philippines), Inc. purchase Mighty Corp.

Details Hidden

Soda Aromatic Co., Ltd., Toray Industries, Inc. purchase Fuji Flavor Co., Ltd. /Flavor Division from Japan Tobacco, Inc.

Subscribe now to see full list of recent transations
Transaction Advisors
Legal Advisor

Advised onJTI (UK) Management Ltd., Japan Tobacco, Inc. purchase Gallaher Group Plc

Accountant

Advised onXiamen Tobacco Industry Co. Ltd. purchases Xiamen Huamei Cigarette Co. Ltd. from Japan Tobacco, Inc.

Legal Advisor

Advised onJapan Tobacco, Inc. purchases International Tobacco Business from R.J. Reynolds Tobacco Holdings, Inc.

Subscribe now to see 10+ more transaction advisors
Legal Advisor

Advised onPhilip Morris International, Inc., Japan Tobacco, Inc. purchase Megapolis Distribution BV from Megapolis Investment BV

Legal Advisor

Advised onJapan Tobacco, Inc. purchases Reynolds American, Inc. /Natural American Cigarettes 9 from Reynolds American, Inc.

Legal Advisor

Advised onPhilip Morris International, Inc., Japan Tobacco, Inc. purchase Megapolis Distribution BV from Megapolis Investment BV

Subscribe now to see 1+ more transaction advisors
Advisors & Consultants
Subscribe now to see advisors & consultants for over 2.5 million organizations
Legal Advisor

Shareholder at Greenberg Traurig LLP

Subscribe now to see advisors & consultants for over 2.5 million organizations
Clients

Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need. In 25 years, Gilead has become a leading biopharmaceutical company with a portfolio of 15 marketed products, a growing pipeline of investigational drugs and approximately 5,000 employees in offices across four continents. Gilead's therapeutic areas of focus include HIV/AIDS, hepatitis, serious respiratory, cardiovascular, and metabolic conditions, cancer and inflammation

Novartis AG develops, manufactures, and markets healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

AstraZeneca Plc is a holding company, which engages in the research, development and manufacture of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 0156, medi 573, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on April 6, 1999 and is headquartered in London, the United Kingdom.

Subscribe now to see 9 more clients
Subscribe now to see clients for over 2.5 million organizations
Key Stats and Financials As of 2017
Market Capitalization
$5.67T
Total Enterprise Value
$7.05T
Earnings Per Share
$219.1
Revenue
$2.14T
Net Profit
$392B
EBITDA
$655B
EBITDAMargin
30.59%
Total Debt
$745B
Total Equity
$2.84T
Enterprise Value Sales
3.29x
Enterprise Value EBITDAOperating
10.77x
TEVNet Income
17.96x
Debt TEV
0.11x
Three Year Compounded Annual Growth Rate Of Revenue
-9.35%
Five Year Compounded Annual Growth Rate Of Revenue
0.18%
Subscribe now to see full financial details
Investments
Details Hidden

Yoshimura Food Holdings KK operates as a holding company which engages in the food business. It manufactures and sells food ingredients, chilled and processed food, noodles, processed meat, sake, liquor, fish pastes and frozen goods, and others. The company was founded by Motohisa Yoshimura on March 18, 2008 and is headquartered in Tokyo, Japan.

Details Hidden

Cyfuse Biomedical KK develops and manufactures cell regenerative systems. It focuses on developing arteries using patient's skin cells and three-dimensional (3D) printing. The firm's business activities encompass development, manufacturing, and sales of 3D tissue products. It also offers Regenova, a robotic system that facilitates the fabrication of 3D cellular structures by placing cellular spheroids in fine needle arrays according to pre-designed 3D data. The company was founded by Koji Kuchiishi and Koichi Nakayama on August 11, 2010 and is headquartered in Tokyo, Japan.

Details Hidden

PAX Labs, Inc. develops and manufactures vaporizers that contain nicotine for smokers. It is leading the reinvention of the smoking experience with its premium vaporizers, and extending the application of vapor science into new medical and nutritional applications. The firm was originally developed with a mission to make smoking obsolete and create an integrated science and technology platform with the potential to disrupt existing tobacco, medical and pharmaceutical industries. The company was founded by Adam Bowen and James Monsees in 2007 and is headquartered in San Francisco, CA.

Subscribe now to see full investment details
Suppliers
Universal Corp. Wholesale: Consumer Non-Durables/Sundries | Richmond, VA

Universal Corp. engages in the processing, procuring, financing, packing, storing, shipping and trading of leaf tobacco. It operates its business through the following business segments: North America, South America, Africa, Europe, Asia, Dark Air-Cured, Oriental and Special Services. The North America, South America, Africa, Europe, and Asia segments are involved in flue-cured and burley leaf tobacco operations. The Dark Air-Cured segment includes supplying of dark air-cured tobacco to manufacturers of cigars, pipe tobacco, and smokeless tobacco products. The Oriental segment supplies oriental tobacco to cigarette manufacturers. The Special Services segment provides laboratory services, including physical and chemical product testing and smoke testing. The company was founded in 1918 and is headquartered in Richmond, VA.

Schweitzer-Mauduit International, Inc. Tobacco | Alpharetta, GA

Schweitzer-Mauduit International, Inc. engages in the provision of engineered solutions, and advanced materials for a variety of industries. It operates through the Engineered Papers and Advanced Materials & Structures segments. The Engineered Papers segment manufactures lightweight specialty papers used in manufacturing banded papers used in the production of lower ignition propensity, cigarettes, and premium specialized papers such as low volume specialized commercial and industrial commodity paper grades. The Advanced Materials & Structure segment refers to the production of resin-based plastic netting and melt blown products, machine plastic core tubes, urethane films, and resin-based rolled products. The company was founded in 1995 and is headquartered in Alpharetta, GA.

Keryx Biopharmaceuticals, Inc. Pharmaceuticals | Boston, MA

Keryx Biopharmaceuticals, Inc. engages in the development and commercialization of medicines for the treatment of renal disease. Its products include phosphate-binding medicines, intravenous iron, and other medications. The company was founded in October 1998 and is headquartered in Boston, MA.

Subscribe now to see 11 more suppliers
Competitors
Imperial Brands Plc Tobacco - Bristol, BI

Imperial Brands Plc engages in the manufacture and sell of cigarettes, tobaccos, cigars, rolling papers, and tubes. It operates through the Tobacco and Logistics segments. The Tobacco segment comprises of manufacture, marketing, and sale of tobacco and tobacco-related products, including sales to the Logistics business. The Logistics segment involves the distribution of tobacco products for tobacco product manufacturers, including Imperial Tobacco. The company was founded in 1901 and is headquartered in Bristol, United Kingdom.

Philip Morris International, Inc. Tobacco - New York, New York

Philip Morris International, Inc. is a holding company, which engages in manufacture and sale of cigarettes and other tobacco and nicotine-containing products. It operates through the following geographical segments: European Union; Eastern, Europe Middles East, and Africa; Asia; and Latin America and Canada. The company was founded by Philip Morris in 1847 and is headquartered in New York, NY.

Altria Group, Inc. Tobacco - Richmond, VA

Altria Group, Inc. is a holding company which engages in the production and market of tobacco products. It operates through the following segments: Smokeable Products, Smokeless Products, and Wine. The Smokeable Products segment comprised of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Smokeless products segment manufactured and sold by or on behalf of USSTC and PM USA. The Wine segment producer of Washington State wines, primarily Chateau Ste. Michelle and Columbia Crest, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.